Promising alternative settings for HPV vaccination of US adolescents
- PMID: 24405401
- PMCID: PMC4267674
- DOI: 10.1586/14760584.2013.871204
Promising alternative settings for HPV vaccination of US adolescents
Abstract
Vaccination in alternative settings, defined here as being outside of traditional primary care, can help address the pressing public health problem of low human papillomavirus vaccine coverage among adolescents in the United States. Pharmacies are promising because they are highly accessible and have well established immunization practices. However, pharmacies currently face policy and reimbursement challenges. School-located mass vaccination programs are also promising because of their high reach and demonstrated success in providing other vaccines, but control by local policymakers and challenges in establishing community partnerships complicate widespread implementation. Health centers in schools are currently too few to greatly increase access to human papillomavirus vaccine. Specialty clinics have experience with vaccination, but the older age of their patient populations limits their reach. Future steps to making alternative settings a success include expanding their use of statewide vaccine registries and improving their coordination with primary care providers.
Similar articles
-
HPV vaccination strategies targeting hard-to-reach populations: Out-of-school girls in LMICs.Vaccine. 2018 Jan 4;36(2):191-193. doi: 10.1016/j.vaccine.2017.11.038. Epub 2017 Dec 1. Vaccine. 2018. PMID: 29198915 No abstract available.
-
Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges.BMC Public Health. 2017 Jun 26;17(1):599. doi: 10.1186/s12889-017-4526-y. BMC Public Health. 2017. PMID: 28651574 Free PMC article.
-
Correlates of comfort with alternative settings for HPV vaccine delivery.Hum Vaccin Immunother. 2013 Feb;9(2):306-13. doi: 10.4161/hv.22614. Epub 2013 Jan 4. Hum Vaccin Immunother. 2013. PMID: 23291948 Free PMC article.
-
Prophylactic human papillomavirus vaccination and primary prevention of cervical cancer: issues and challenges.Clin Microbiol Infect. 2012 Oct;18 Suppl 5:64-9. doi: 10.1111/j.1469-0691.2012.03946.x. Epub 2012 Aug 6. Clin Microbiol Infect. 2012. PMID: 22862799 Review.
-
Moving forward: human papillomavirus vaccination and the prevention of cervical cancer.J Womens Health (Larchmt). 2007 Nov;16(9):1258-68. doi: 10.1089/jwh.2007.0493. J Womens Health (Larchmt). 2007. PMID: 18001182 Review.
Cited by
-
Barriers and determinants of consistent offering of HPV vaccination by healthcare facilities.Hum Vaccin Immunother. 2023 Aug;19(2):2264596. doi: 10.1080/21645515.2023.2264596. Epub 2023 Oct 17. Hum Vaccin Immunother. 2023. PMID: 37846730 Free PMC article.
-
Quality of physician communication about human papillomavirus vaccine: findings from a national survey.Cancer Epidemiol Biomarkers Prev. 2015 Nov;24(11):1673-9. doi: 10.1158/1055-9965.EPI-15-0326. Epub 2015 Oct 22. Cancer Epidemiol Biomarkers Prev. 2015. PMID: 26494764 Free PMC article.
-
Overcoming Barriers to Low HPV Vaccine Uptake in the United States: Recommendations from the National Vaccine Advisory Committee: Approved by the National Vaccine Advisory Committee on June 9, 2015.Public Health Rep. 2016 Jan-Feb;131(1):17-25. doi: 10.1177/003335491613100106. Public Health Rep. 2016. PMID: 26843665 Free PMC article. No abstract available.
-
Post-Vaccination Anaphylaxis in Adults: A Systematic Review and Meta-Analysis.Vaccines (Basel). 2025 Jan 4;13(1):37. doi: 10.3390/vaccines13010037. Vaccines (Basel). 2025. PMID: 39852816 Free PMC article. Review.
-
Adolescent Vaccination Strategies: Interventions to Increase Coverage.Paediatr Drugs. 2016 Aug;18(4):273-85. doi: 10.1007/s40272-016-0177-1. Paediatr Drugs. 2016. PMID: 27146296 Review.
References
-
- Smith JS, Lindsay L, Hoots B, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer. 2007;121(3):621–32. - PubMed
-
- Newmann SJ, Garner EO. Social inequities along the cervical cancer continuum: a structured review. Cancer Causes Control. 2005;16(1):63–70. - PubMed
-
- Markowitz LE, Dunne E, Saraiya M, et al. Quadrivalent human papillomavirus vaccine. MMWR Morb Mortal Wkly Rep. 2007;56(RR02):1–24. - PubMed
-
- Dunne E, Markowitz L, Chesson H, et al. Recommendations on the use of quadrivalent human papillomavirus vaccine in males–Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011;60(50):1705–8. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical